Fecal transplant for digestive side effects in neuroendocrine cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests whether giving patients healthy donor stool bacteria (fecal microbiota transplantation) can reduce or prevent nausea, diarrhea, and other stomach or bowel problems caused by cancer treatment. It is for people with extrapulmonary neuroendocrine tumors who have had gastrointestinal side effects during their first three treatment cycles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of extrapulmonary neuroendocrine neoplasm (a type of tumor that starts outside the lungs).
- You have experienced side effects like diarrhea, constipation, nausea, or vomiting within the first 3 treatment cycles.
- You are expected to live at least 3 more months.
- You are able to swallow capsules without chewing.
- You have not taken antibiotics by mouth or IV in the 3 days before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fecal transplant (a stool donation from a healthy person) can help patients with advanced stomach cancer respond better to treatment. If you qualify, you would receive the transplant through a colonoscopy, possibly along with other standard therapies.
This trial tests a treatment called “washed microbiota transplant,” which transfers healthy gut bacteria to help relieve intestinal problems that started after cancer therapy. You might benefit if you’re an adult with certain ongoing stomach or bowel symptoms after standard cancer treatment, and your body is stable enough for the procedure.
This trial tests a combination of fecal microbiota transplant (FMT), chemotherapy (SOX), and an immunotherapy drug (Sintilimab) as a first treatment for advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery. The goal is to see if this combination can shrink tumors and improve outcomes.
This trial tests whether fecal transplants (putting healthy donor bacteria into your gut) can help with side effects like diarrhea, constipation, or nausea caused by cancer treatments. It is for people with advanced gastrointestinal cancer who are about to start their fourth round of chemo or targeted therapy.
This trial tests whether transplanting healthy donor bacteria (fecal microbiota) into the gut can help adults with blood cancers who have stubborn infections, C. diff, or complications after stem cell transplant. It may reduce dangerous germs and improve gut health.
This study tests whether transplanting healthy donor stool into the gut can help children and young adults with ongoing digestive issues after a stem cell transplant. It may improve symptoms like diarrhea or the need for feeding tubes.
Hear when a new Treatment-related Gastrointestinal Toxicity (Including Diarrhea, Constipation, Nausea, and Vomiting) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.